Suppr超能文献

过氧化物酶体增殖物激活受体 γ 及其在脂肪细胞稳态和噻唑烷二酮介导的胰岛素敏感性中的作用。

Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.

机构信息

Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Department of Molecular & Cellular Endocrinology, Diabetes and Metabolism Research Institute, City of Hope/Beckman Research Institute, Duarte, California, USA.

出版信息

Mol Cell Biol. 2018 Apr 30;38(10). doi: 10.1128/MCB.00677-17. Print 2018 May 15.

Abstract

Adipose tissue is a dynamic organ that makes critical contributions to whole-body metabolic homeostasis. Although recent studies have revealed that different fat depots have distinct molecular signatures, metabolic functions and adipogenic mechanisms, peroxisome proliferator-activated receptor γ (PPARγ) is still widely viewed as the master regulator of adipogenesis and critical for maintaining mature adipocyte function. Using an inducible, adipocyte-specific knockout system, we explored the role of PPARγ in mature adipocytes Short-term PPARγ deficiency in adipocytes reduces whole-body insulin sensitivity, but adipocytes are viable both and However, after exposure to a high-fat diet, even short-term PPARγ deficiency leads to rapid adipocyte death. When mature adipocytes are depleted of both PPARγ and CCAAT-enhancer-binding protein α (C/EBPα), they are rapidly depleted of lipids and undergo adipocyte death, both and Surprisingly, although thiazolidinediones (TZDs; PPARγ agonists) are thought to act mainly on PPARγ, PPARγ in adipocytes is not required for the whole-body insulin-sensitizing effect of TZDs. This offers new mechanistic aspects of PPARγ/TZD action and its effect on whole-body metabolic homeostasis.

摘要

脂肪组织是一个动态的器官,对全身代谢稳态起着至关重要的作用。尽管最近的研究揭示了不同的脂肪储存库具有不同的分子特征、代谢功能和脂肪生成机制,但过氧化物酶体增殖物激活受体 γ(PPARγ)仍然被广泛认为是脂肪生成的主要调节剂,对维持成熟脂肪细胞的功能至关重要。我们使用一种诱导型、脂肪细胞特异性敲除系统,探讨了 PPARγ 在成熟脂肪细胞中的作用。短期 PPARγ 缺乏会降低全身胰岛素敏感性,但脂肪细胞在 和 条件下仍然具有活力。然而,在暴露于高脂肪饮食后,即使是短期的 PPARγ 缺乏也会导致脂肪细胞迅速死亡。当成熟脂肪细胞同时缺乏 PPARγ 和 CCAAT 增强子结合蛋白 α(C/EBPα)时,它们会迅速耗尽脂肪并发生脂肪细胞死亡,在 和 条件下都是如此。令人惊讶的是,尽管噻唑烷二酮类药物(TZDs;PPARγ 激动剂)被认为主要作用于 PPARγ,但脂肪细胞中的 PPARγ 并不是 TZDs 发挥全身胰岛素增敏作用所必需的。这为 PPARγ/TZD 作用及其对全身代谢稳态的影响提供了新的机制方面。

相似文献

8
Mechanisms regulating adipocyte expression of resistin.调节脂肪细胞抵抗素表达的机制。
J Biol Chem. 2002 May 31;277(22):19754-61. doi: 10.1074/jbc.M201451200. Epub 2002 Mar 18.

引用本文的文献

本文引用的文献

1
Targeting adipose tissue in the treatment of obesity-associated diabetes.靶向脂肪组织治疗肥胖相关性糖尿病。
Nat Rev Drug Discov. 2016 Sep;15(9):639-660. doi: 10.1038/nrd.2016.75. Epub 2016 Jun 3.
7
What we talk about when we talk about fat.我们谈论脂肪时在谈论什么。
Cell. 2014 Jan 16;156(1-2):20-44. doi: 10.1016/j.cell.2013.12.012.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验